Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricSNYSanofi SAGSKGSK plcBMYBristol Myers Squibb
Snapshot
Price$39.89$47.10$60.77
Market cap$98.73B$102.51B$118.71B
Valuation
P/E7.4x13.8x20.8x
Forward P/E5.3x9.8x16.5x
Growth
Revenue growth43.7%4.0%1.8%
EPS growth96.2%86.7%26.3%
Profitability
Net margin17.2%17.8%12.3%
ROE17.0%35.8%41.6%
Balance sheet & cash
Debt / equity0.28x1.08x2.44x
Free cash flow yield21.4%3.8%15.4%
Dividend yield5.4%3.5%4.5%
Verdict
Investment ratingStrong· 80Favorable· 66Favorable· 60

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearSNYtoday $40GSKtoday $47BMYtoday $61
2027$58.70 – $86.09+116% CAGR$65.96 – $96.74+105% CAGR$57.55 – $84.41+39% CAGR
2028$115.17 – $168.91+106% CAGR$123.17 – $180.65+96% CAGR$72.67 – $106.58+32% CAGR
2029$225.96 – $331.40+103% CAGR$230.00 – $337.33+93% CAGR$91.76 – $134.58+30% CAGR
2030$443.32 – $650.21+101% CAGR$429.48 – $629.90+91% CAGR$115.86 – $169.93+29% CAGR
2031$869.80 – $1,275.71+100% CAGR$801.96 – $1,176.21+90% CAGR$146.30 – $214.58+29% CAGR
5-yr CAGR85.2% – 100.0%76.3% – 90.3%19.2% – 28.7%